-
Psyched: Boston Suburbs Decriminalize Psilocybin, Delic Begins Psychedelic Treatments, Australia Denies Legalization
Saturday, February 6, 2021 - 9:37am | 1449Boston Suburbs Look To Decriminalize Natural Psychedelics Two Boston suburbs are the latest U.S. jurisdictions to eliminate penalties on the possession and cultivation of entheogenic plants and fungi. That includes psilocybin mushrooms, ayahuasca, the peyote cacti and the iboga...
-
Delic Enters Psychedelic Treatment With New Acquisition, Names New CEO
Thursday, February 4, 2021 - 3:49pm | 310Psychedelics media and events company Delic Holdings (CSE: DELC) (OTCQB: DELCF) is taking its first steps into patient treatment with the acquisition of two ketamine infusion treatment clinics. The clinics are operated by Ketamine Infusion Centers LLC, and located in Phoenix, Arizona and...
-
Delic: Advancing Psychedelics Education With Help From The Public Markets
Thursday, December 10, 2020 - 3:59pm | 941Delic Holdings Inc. (CSE:DELC), an e-commerce company focused on the nascent psychedelics industry, recently went public on the Canadian Securities Exchange. In mid-November, the Vancouver-based company completed a reverse take-over with Molystar Resources Inc. Most companies in the...
-
Psyched: St. Vincent OKs Psychedelics Program, Delic To Go Public, Field Trip Drug Update
Saturday, October 31, 2020 - 2:41pm | 987Saint Vincent Okays Psychedelic Initiative The Caribbean country of Saint Vincent and the Grenadines has approved an initiative to incentivize psychedelic research and wellness. The small English-speaking island nation, located about 100 miles north of Venezuela’s coast, has passed a...
-
Psychedelics Company Delic Corp. To Go Public On The CSE
Saturday, October 24, 2020 - 12:18pm | 303E-commerce and events company Delic Corp., which is focused on the psychedelics industry, recently announced it would be going public on the Canadian Securities Exchange via a reverse takeover (RTO) of Molystar Resources Inc. The closing of the RTO will take place by Nov. 30, Benzinga...
-
Psyched: Compass Joins Nasdaq, Field Trip Goes Public, MindMed Begins Trials, ATAI Launches MDMA Subsidiary
Friday, September 4, 2020 - 8:51am | 1225Compass Pathways Files for an IPO at NASDAQ UK-based Compass Pathways wants to become the first psychedelics company to list on a major U.S. stock exchange. The psilocybin research company intends to make its initial public offering (IPO) through NASDAQ under the ticker symbol...